Q4 2019

Filed Mar 30, 2020 · 10-K · 90 days after period end · 0001493152-20-005264

Q4 2019 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$0.00

derivedno prior Q4 2018 on file

Net Income

-$42.30K

derivedno prior Q4 2018 on file

EPS, diluted—Not derived. Share counts vary by quarter.

Same quarter

no prior Q4 2018 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR